Bérengère Ize

Bérengère Ize

Auto-generated profile, based on publicly available information

Bérengère Ize

Laboratoire d’Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ESEliza Ye-Chen Soh
Eliza Ye-Chen Soh
FSFrances Smith
Frances Smith
MGMaxime Rémi Gimenez
Maxime Rémi Gimenez
LYLiang Yang
Liang Yang
RVRebecca Munk Vejborg
Rebecca Munk Vejborg
PWPaul Williams
Paul Williams
Extracellular DNA (eDNA) is a major constituent of the extracellular matrix ofPseudomonas aeruginosabiofilms and its release is regulated via pseudomonas quinolone signal (PQS) dependent quorum sensing (QS). By screening aP.aeruginosatransposon library to identify factors required for DNA release, mutants with insertions in the twin-arginine translocation (Tat) pathway were identified as exhibiting reduced eDNA release, and defective biofilm architecture with enhanced susceptibility to tobramycin.P.aeruginosa tatmutants showed substantial reductions in pyocyanin, rhamnolipid and membrane vesicle (MV) production consistent with perturbation of PQS-dependent QS as demonstrated by changes inpqsAexpression and 2-alkyl-4-quinolone (AQ) production. Provision of exogenous PQS to thetatmutants did not returnpqsA,rhlAorphzA1expression or pyocyanin production to wild type levels. However, transformation of thetatmutants with the AQ-independentpqseffectorpqsErestoredphzA1expression and pyocyanin production. Since mutation or inhibition of Tat prevented PQS-driven auto-induction, we sought to identify the Tat substrate(s) responsible. ApqsA::luxfusion was introduced into each of 34 validatedP.aeruginosaTat substrate deletion mutants. Analysis of each mutant for reduced bioluminescence revealed that the primary signalling defect was associated with the Rieske iron-sulfur subunit of the cytochromebc1complex. In common with the parent strain, a Rieske mutant exhibited defective PQS signalling, AQ production,rhlAexpression and eDNA release that could be restored by genetic complementation. This defect was also phenocopied by deletion ofcytBorcytC1. Thus, either lack of the Rieske sub-unit or mutation of cytochromebc1genes results in the perturbation of PQS-dependent autoinduction resulting in eDNA deficient biofilms, reduced antibiotic tolerance and compromised virulence factor production.

9 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGMaxime Rémi Gimenez
Maxime Rémi Gimenez
GCGovind Chandra
Govind Chandra
POPerrine Van Overvelt
Perrine Van Overvelt
RVRomé Voulhoux
Romé Voulhoux
SBSophie Bleves
Sophie Bleves
BIBérengère Ize
Bérengère Ize
In bacteria, the twin-arginine translocation (Tat) pathway allows the export of folded proteins through the inner membrane. Proteins targeted to this system are synthesized with N-terminal signal peptides bearing a conserved twin-arginine motif. The Tat pathway is critical for many bacterial processes including pathogenesis and virulence. However, the full set of Tat substrates is unknown in many bacteria, and the reliability ofin silicoprediction methods largely uncertain. In this work, we performed a combination ofin silicoanalysis and experimental validation to identify a core set of Tat substrates in the opportunistic pathogenPseudomonas aeruginosa.In silicoanalysis predicted 44 putative Tat signal peptides in theP. aeruginosaPA14 proteome. We developed an improved amidase-based Tat reporter assay to show that 33 of these are real Tat signal peptides. In addition,in silicoanalysis of the full translated genome revealed a Tat candidate with a missassigned start codon. We showed that it is a new periplasmic protein inP. aeruginosa. Altogether we discovered and validated 34 Tat substrates. These show little overlap withEscherichia coliTat substrates, and functional analysis points to a general role for theP. aeruginosaTat system in the colonization of environmental niches and pathogenicity.

2 April 2019 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
MMMalika Moussouni
Malika Moussouni
PNPauline NOGARET
Pauline NOGARET
PGPreeti Garai
Preeti Garai
BIBérengère Ize
Bérengère Ize
EVEric Vives
Eric Vives
Anne Blanc-PotardAnne Blanc-Potard
Anne Blanc-Potard
Antivirulence strategies aim to target pathogenicity factors while bypassing the pressure on the bacterium to develop resistance. The MgtC membrane protein has been proposed as an attractive target that is involved in the ability of several major bacterial pathogens, including Pseudomonas aeruginosa, to survive inside macrophages. In liquid culture, P. aeruginosa MgtC acts negatively on biofilm formation. However, a putative link between these two functions of MgtC in P. aeruginosa has not been experimentally addressed. In the present study, we first investigated the contribution of exopolysaccharides (EPS) in the intramacrophage survival defect and biofilm increase of mgtC mutant. Within infected macrophages, expression of EPS genes psl and alg was increased in a P. aeruginosa mgtC mutant strain comparatively to wild-type strain. However, the intramacrophage survival defect of mgtC mutant was not rescued upon introduction of psl or alg mutation, suggesting that MgtC intramacrophage role is unrelated to EPS production, whereas the increased biofilm formation of mgtC mutant was partially suppressed by introduction of psl mutation. We aimed to develop an antivirulence strategy targeting MgtC, by taking advantage of a natural antagonistic peptide, MgtR. Heterologous expression of mgtR in P. aeruginosa PAO1 was shown to reduce its ability to survive within macrophages. We investigated for the first time the biological effect of a synthetic MgtR peptide on P. aeruginosa. Exogenously added synthetic MgtR peptide lowered the intramacrophage survival of wild-type P. aeruginosa PAO1, thus mimicking the phenotype of an mgtC mutant as well as the effect of endogenously produced MgtR peptide. In correlation with this finding, addition of MgtR peptide to bacterial culture strongly reduced MgtC protein level, without reducing bacterial growth or viability, thus differing from classical antimicrobial peptides. On the other hand, the addition of exogenous MgtR peptide did not affect significantly biofilm formation, indicating an action toward EPS-independent phenotype rather than EPS-related phenotype. Cumulatively, our results show an antivirulence action of synthetic MgtR peptide, which may be more potent against acute infection, and provide a proof of concept for further exploitation of anti-Pseudomonas strategies.

29 March 2014
Verified
Book Chapter
Closed access
PDF file
BIBérengère Ize
Bérengère Ize
VVVéronique Viarre
Véronique Viarre
RVRomé Voulhoux
Romé Voulhoux

22 January 2025 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
AGAudrey Goman
Audrey Goman
BIBérengère Ize
Bérengère Ize
KJKaty Jeannot
Katy Jeannot
CPCamille Pin
Camille Pin
DPDelphine Payros
Delphine Payros
Eric OswaldEric Oswald
Eric Oswald
CprA is a short‐chain dehydrogenase/reductase (SDR) that contributes to resistance against colistin and antimicrobial peptides. The cprA gene is conserved across Pseudomonas aeruginosa clades and its expression is directly regulated by the two‐component system PmrAB. We have shown that cprA expression leads to the production of outer membrane vesicles (OMVs) that block autophagic flux and have a greater capacity to activate the non‐canonical inflammasome pathway. In a murine model of sepsis, a P. aeruginosa strain deleted for cprA was less virulent than the wild‐type (WT) strain. These results demonstrate the important role of CprA in the pathogenicity of P. aeruginosa. It is worth noting that CprA is also a functional ortholog of hemolysin F (HlyF), which is encoded by virulence plasmids of Escherichia coli. We have shown that other cryptic SDRs encoded by mammalian and plant pathogens, such as Yersinia pestis and Ralstonia solanacearum are functional orthologs of CprA and HlyF. These SDRs also induce the production of OMVs which block autophagic flux. This study uncovers a new family of virulence determinants in Gram‐negative bacteria, offering potential for innovative therapeutic interventions and deeper insights into bacterial pathogenesis.

1 March 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ESEliza Ye-Chen Soh
Eliza Ye-Chen Soh
FSFrances Smith
Frances Smith
MGMaxime Rémi Gimenez
Maxime Rémi Gimenez
LYLiang Yang
Liang Yang
RVRebecca Munk Vejborg
Rebecca Munk Vejborg
PWPaul Williams
Paul Williams
Extracellular DNA (eDNA) is a major constituent of the extracellular matrix of Pseudomonas aeruginosa biofilms and its release is regulated via the pseudomonas quinolone signal (PQS) dependent quorum sensing (QS). By screening a P. aeruginosa transposon library to identify factors required for DNA release, mutants with insertions in the twin-arginine translocation (Tat) pathway were identified as exhibiting reduced eDNA release, and defective biofilm architecture with enhanced susceptibility to tobramycin. P. aeruginosa tat mutants showed substantial reductions in pyocyanin, rhamnolipid and membrane vesicle (MV) production consistent with perturbation of 2-heptyl-3-hydroxy-4-quinolone (PQS) dependent QS as demonstrated by changes in pqsA expression and 2-alkyl-4-quinolone (AQ) production. Provision of exogenous PQS to the tat mutants did not return pqsA , rhlA or phzA1 expression or pyocyanin production to wild type levels. However, transformation of the tat mutants with the AQ-independent pqs effector pqsE restored phzA1 expression and pyocyanin production. Since mutation or inhibition of Tat prevented PQS-driven auto-induction, we sought to identify the Tat secretion substrate responsible. A pqsA::lux fusion was introduced into each of 34 validated P. aeruginosa Tat substrate deletion mutants. Analysis of each mutant for reduced bioluminescence revealed that the signalling defect was associated with the Rieske iron-sulfur subunit of the cytochrome bc 1 complex. In common with the parent strain, a Rieske mutant exhibited defective PQS signalling, AQ production, rhlA expression and eDNA release that could be restored by genetic complementation. Thus, lack of the Rieske sub-unit export is clearly responsible for the Tat-mediated perturbation of PQS-dependent QS, the loss of virulence factor production, biofilm eDNA and the tobramycin tolerance of P. aeruginosa biofilms. Author Summary: Pseudomonas aeruginosa is a highly adaptable human pathogen responsible for causing chronic biofilm-associated infections. Biofilms are highly refractory to host defences and antibiotics and thus difficult to eradicate. The biofilm extracellular matrix incorporates extracellular DNA (eDNA). This stabilizes biofilm architecture and helps confer tolerance to antibiotics. Since mechanisms that control eDNA release are not well understood, we screened a P. aeruginosa mutant bank for strains with defects in eDNA release and discovered a role for the twin-arginine translocation (Tat) pathway that exports folded proteins across the cytoplasmic membrane. Perturbation of the Tat pathway resulted in defective biofilms susceptible to antibiotic treatment as a consequence of perturbed pseudomonas quinolone (PQS) signalling. This resulted in the failure to produce or release biofilm components including eDNA, phenazines and rhamnolipids as well as microvesicles. Furthermore, we discovered that perturbation of PQS signalling was a consequence of the inability of tat mutants to translocate the Rieske subunit of the cytochrome bc 1 complex involved in electron transfer and energy transduction. Given the importance of PQS signalling and the Tat system to virulence and biofilm maturation in P. aeruginosa , our findings underline the potential of the Tat system as a drug target for novel antimicrobial agents.